On Monday, March 16, 2015, I was honored to speak at Patients as Partners, a conference dedicated to finding solutions on how to truly partner with patients in clinical trials. Representatives from pharma, PCORI, CTTI, FasterCures, FDA, patient advocates and patients all came together in Philadelphia for this important discussion.

Many role-models and friends were in attendance and speaking -innovative movers and shakers challenging the status-quo in healthcare and drug development to ensure that the patient voice is included.

My presentation, “How a Patient Helped Define a New Clinical Endpoint in Narcolepsy”, shared my story of helping to define a new clinical endpoint with FDA and what this can mean for the future of the drug development.

Afterward, I joined a panel on how to get the patient voice into the regulatory process with
 Anna McCollister-Slipp
, Patient Representative with type 1 diabetes and Co-Founder of Galileo Analytics, 
and 
Theresa Mullin, Ph.D.
, Director of FDA’s  Office of Strategic Programs. Dr. Mullin is a personal hero of mine, so to share the stage with her was surreal and unforgettable.

Thank you to Valerie and the Conference Forum for putting together a thought-provoking and inspiring conference.

My speech was not recorded, but you can watch a similar one here: 

Also, an interview on narcolepsy, FDA and Project Sleep:

Upcoming Speaking Engagements:

• Narcolepsy Support Australia Inaugural Patient Conference May 1-3, 2015.
• Nova Southeastern University, Grand Rounds to faculty followed by a presentation for students and other healthcare professionals, May 6, 2015
• Hypersomnia Foundation Conference, July 17-18, 2015
• Stanford Medicine X, September 23-24, 2015

Book me for an upcoming conference. View speaker’s resume.